Throughout his career as a drug developer, including five marketed products, Dr. Rick Graham repeatedly encountered clinical trial situations that came dangerously close to compromising programs – not for scientific reasons, but because preventable clinical trial execution issues surfaced too late to address.

From regulatory reviews paused by data discrepancies, to pharmacokinetic and biomarker analyses clouded by spurious results, to irreplaceable samples lost in transit, these moments carried serious scientific, regulatory, and commercial consequences.

In this fireside chat, Dr. Graham shares the real-world experiences that led him to found TruTechnologies, and why he believes real-time clinical trial oversight is one of the most underestimated drivers of trial success.

What you’ll learn:

• How invisible site-level issues can compromise biological sample data, undermine statistical power, and lead to regulatory risk

• Why many clinical trial execution failures are preventable, but discovered too late under traditional approaches

• How sponsors are utilizing real-time clinical trial oversight to intervene earlier, reduce noise, and protect study outcomes